Rubella diagnostic issues in Canada

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 2, 2011, Pages

  Tipples, Graham A ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; CANADA; CONGENITAL RUBELLA SYNDROME; EPIDEMIC; HEALTH SURVEY; HUMAN; INFECTION CONTROL; LABORATORY DIAGNOSIS; MOLECULAR EPIDEMIOLOGY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; RUBELLA; RUBELLA VIRUS; SEROLOGY; VIRUS DETECTION; VIRUS TRANSMISSION; ANTIBODY TITER; BLOOD SAMPLING; DENGUE; DIFFERENTIAL DIAGNOSIS; DISEASE SURVEILLANCE; FALSE POSITIVE RESULT; FEVER; MACULOPAPULAR RASH; MEASLES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRUS ISOLATION;

ADULT; ALGORITHMS; ANTIBODIES, VIRAL; CANADA; FEMALE; HUMANS; IMMUNOGLOBULIN M; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RUBELLA; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 80053396128     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir430     Document Type: Article

References (20)

1. King A, Varughese P, De Serres G, Tipples GA, Waters J; Working Group on Measles Elimination. Measles elimination in Canada. J Infect Dis 2004; 189:S236-42.
2. Macey J, Tam T, Lipskie T, Tipples GA, EisBrenner T. Rubella elimination, the Canadian experience. J Infect Dis 2009; 10.1093/infdis/JIR406.
3. Tipples GA, Hamkar R, Mohktari-Azad T, et al. Evaluation of rubella IgM enzyme immunoassays. J Clin Virol 2004; 30:233-8. (Pubitemid 38622005)
4. Bustos J, Hamdan A, Lorono MA, Montero MT, Gomez B. Serologically proven acute rubella infection in patients with clinical diagnosis of dengue. Epidemiol Infect 1990; 104:297-302. (Pubitemid 20300144)
5. Dietz VJ, Nieburg P, Gubler DJ, Gomez I. Diagnosis of measles by clinical case definition in dengue-endemic areas: implications for measles surveillance and control. Bull World Health Organ 1992; 70:745-50. (Pubitemid 23032579)
6. Oliveira SA, Siqueira MM, Camacho LA, et al. The aetiology of maculopapular rash diseases in Niteroi, State of Rio de Janeiro, Brazil: implications for measles surveillance. Epidemiol Infect 2001; 127:509-16. (Pubitemid 34092798)
7. World Health Organization. Chapter 2, clinical diagnosis. In: Dengue haemorrhagic fever: diagnosis, treatment, prevention and control, 2nd ed. Geneva, Switzerland: World Health Organization, 1997:12-23.
8. Deen JL, Harris E, Wills B, et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006; 368:170-3. (Pubitemid 43994174)
9. Cutts FT, Brown DWG. The contribution of field tests to measles surveillance and control: a review of available methods. Rev Med Virol 1995; 5:35-40. (Pubitemid 26096351)
10. Pellet P, Tipples GA. Human herpesviruses 6, 7 and 8. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, eds. Manual of clinical microbiology. 9th ed. Washington, DC: ASM Press, 2007:1574-88.
11. Best JM, O'Shea S, Tipples G, et al. Interpretation of rubella serology in pregnancy-pitfalls and problems. BMJ 2002; 325:147-8. (Pubitemid 34800130)
12. Thomas HI, Morgan-Capner P. Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect 1988; 101:591-8. (Pubitemid 19034448)
13. Thomas HI, Morgan-Capner P. Rubella-specific IgG1 avidity: a comparison of methods. J Virol Methods 1991; 31:219-28.
14. Mubareka S, Richards H, Gray M, Tipples GA. Evaluation of commercial rubella immunoglobulin G avidity assays. J Clin Microbiol 2007; 45:231-3. (Pubitemid 46106433)
15. World Health Organization. Manual for the laboratory diagnosis of measles and rubella virus infection. 2nd ed. Geneva, Switzerland: World Health Organization; 2007.
16. World Health Organization, Global Measles and Rubella Laboratory Network. Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. Wkly Epidemiol Rec 2005; 80: 126-32.
17. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982; 2: 781-4. (Pubitemid 12068990)
18. Morgan-Capner P, Crowcroft NS. PHLS Joint Working Party of the Advisory Committees of Virology and Vaccines and Immunisation. Guidelines on the management of, and exposure to, rash illness in pregnancy. Commun Dis Public Health 2002; 5:59-71.
19. Banatvala JE, Brown DW. Rubella. Lancet 2004; 363:1127-37. (Pubitemid 38452787)
20. Best JM, Banatvala JE. Rubella. In: Zuckerman AJ, ed. Principles and practice of clinical virology, 5th ed. Hoboken, NJ: John Wiley and Sons, 2004; 427-58.